ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hepatitis A immunoglobulin Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-17D12859
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Hepatitis A immunoglobulin Market Research Report 2022
BUY CHAPTERS

Global Hepatitis A immunoglobulin Market Research Report 2025

Code: QYRE-Auto-17D12859
Report
March 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
SINOVAC BIOTECH
GSK
Sanofi
Dr. Reddy’s Laboratories
AIM Vaccine
Pukang Biotechnology
Zhifei Biological Products
Changchun Lnstitute Of Biological Products
Native Antigen
Merck
CSL Behring

Hepatitis A immunoglobulin Market

The global market for Hepatitis A immunoglobulin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Hepatitis A immunoglobulin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Hepatitis A immunoglobulin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Hepatitis A immunoglobulin include CSL Behring, AIM Vaccine, Sinovac Biotech, Pukang Biotechnology, Zhifei Biological Products, Changchun Lnstitute Of Biological Products, Native Antigen, GSK, Merck, Sanofi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hepatitis A immunoglobulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis A immunoglobulin.
The Hepatitis A immunoglobulin market size, estimations, and forecasts are provided in terms of sales volume (Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hepatitis A immunoglobulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis A immunoglobulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hepatitis A immunoglobulin Market Report

Report Metric Details
Report Name Hepatitis A immunoglobulin Market
Segment by Type
Segment by Application
  • Hospital
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company CSL Behring, AIM Vaccine, Sinovac Biotech, Pukang Biotechnology, Zhifei Biological Products, Changchun Lnstitute Of Biological Products, Native Antigen, GSK, Merck, Sanofi, Dr. Reddy's Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Hepatitis A immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Hepatitis A immunoglobulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Hepatitis A immunoglobulin Market report?

Ans: The main players in the Hepatitis A immunoglobulin Market are CSL Behring, AIM Vaccine, Sinovac Biotech, Pukang Biotechnology, Zhifei Biological Products, Changchun Lnstitute Of Biological Products, Native Antigen, GSK, Merck, Sanofi, Dr. Reddy's Laboratories

What are the Application segmentation covered in the Hepatitis A immunoglobulin Market report?

Ans: The Applications covered in the Hepatitis A immunoglobulin Market report are Hospital, Pharmacy, Other

What are the Type segmentation covered in the Hepatitis A immunoglobulin Market report?

Ans: The Types covered in the Hepatitis A immunoglobulin Market report are Inactivated, Attenuated

Recommended Reports

Hepatitis Related Markets

Immunoglobulin Markets

Liver and Antiviral Therapy

1 Hepatitis A immunoglobulin Market Overview
1.1 Product Definition
1.2 Hepatitis A immunoglobulin by Type
1.2.1 Global Hepatitis A immunoglobulin Market Value Comparison by Type (2024 VS 2031)
1.2.2 Inactivated
1.2.3 Attenuated
1.3 Hepatitis A immunoglobulin by Application
1.3.1 Global Hepatitis A immunoglobulin Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Hepatitis A immunoglobulin Market Size Estimates and Forecasts
1.4.1 Global Hepatitis A immunoglobulin Revenue 2020-2031
1.4.2 Global Hepatitis A immunoglobulin Sales 2020-2031
1.4.3 Global Hepatitis A immunoglobulin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hepatitis A immunoglobulin Market Competition by Manufacturers
2.1 Global Hepatitis A immunoglobulin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hepatitis A immunoglobulin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hepatitis A immunoglobulin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hepatitis A immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hepatitis A immunoglobulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hepatitis A immunoglobulin, Product Type & Application
2.7 Global Key Manufacturers of Hepatitis A immunoglobulin, Date of Enter into This Industry
2.8 Global Hepatitis A immunoglobulin Market Competitive Situation and Trends
2.8.1 Global Hepatitis A immunoglobulin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hepatitis A immunoglobulin Players Market Share by Revenue
2.8.3 Global Hepatitis A immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hepatitis A immunoglobulin Market Scenario by Region
3.1 Global Hepatitis A immunoglobulin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hepatitis A immunoglobulin Sales by Region: 2020-2031
3.2.1 Global Hepatitis A immunoglobulin Sales by Region: 2020-2025
3.2.2 Global Hepatitis A immunoglobulin Sales by Region: 2026-2031
3.3 Global Hepatitis A immunoglobulin Revenue by Region: 2020-2031
3.3.1 Global Hepatitis A immunoglobulin Revenue by Region: 2020-2025
3.3.2 Global Hepatitis A immunoglobulin Revenue by Region: 2026-2031
3.4 North America Hepatitis A immunoglobulin Market Facts & Figures by Country
3.4.1 North America Hepatitis A immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hepatitis A immunoglobulin Sales by Country (2020-2031)
3.4.3 North America Hepatitis A immunoglobulin Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hepatitis A immunoglobulin Market Facts & Figures by Country
3.5.1 Europe Hepatitis A immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hepatitis A immunoglobulin Sales by Country (2020-2031)
3.5.3 Europe Hepatitis A immunoglobulin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hepatitis A immunoglobulin Market Facts & Figures by Region
3.6.1 Asia Pacific Hepatitis A immunoglobulin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hepatitis A immunoglobulin Sales by Region (2020-2031)
3.6.3 Asia Pacific Hepatitis A immunoglobulin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Hepatitis A immunoglobulin Market Facts & Figures by Country
3.7.1 Latin America Hepatitis A immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hepatitis A immunoglobulin Sales by Country (2020-2031)
3.7.3 Latin America Hepatitis A immunoglobulin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hepatitis A immunoglobulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Hepatitis A immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hepatitis A immunoglobulin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hepatitis A immunoglobulin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hepatitis A immunoglobulin Sales by Type (2020-2031)
4.1.1 Global Hepatitis A immunoglobulin Sales by Type (2020-2025)
4.1.2 Global Hepatitis A immunoglobulin Sales by Type (2026-2031)
4.1.3 Global Hepatitis A immunoglobulin Sales Market Share by Type (2020-2031)
4.2 Global Hepatitis A immunoglobulin Revenue by Type (2020-2031)
4.2.1 Global Hepatitis A immunoglobulin Revenue by Type (2020-2025)
4.2.2 Global Hepatitis A immunoglobulin Revenue by Type (2026-2031)
4.2.3 Global Hepatitis A immunoglobulin Revenue Market Share by Type (2020-2031)
4.3 Global Hepatitis A immunoglobulin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hepatitis A immunoglobulin Sales by Application (2020-2031)
5.1.1 Global Hepatitis A immunoglobulin Sales by Application (2020-2025)
5.1.2 Global Hepatitis A immunoglobulin Sales by Application (2026-2031)
5.1.3 Global Hepatitis A immunoglobulin Sales Market Share by Application (2020-2031)
5.2 Global Hepatitis A immunoglobulin Revenue by Application (2020-2031)
5.2.1 Global Hepatitis A immunoglobulin Revenue by Application (2020-2025)
5.2.2 Global Hepatitis A immunoglobulin Revenue by Application (2026-2031)
5.2.3 Global Hepatitis A immunoglobulin Revenue Market Share by Application (2020-2031)
5.3 Global Hepatitis A immunoglobulin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Company Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSL Behring Hepatitis A immunoglobulin Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 AIM Vaccine
6.2.1 AIM Vaccine Company Information
6.2.2 AIM Vaccine Description and Business Overview
6.2.3 AIM Vaccine Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AIM Vaccine Hepatitis A immunoglobulin Product Portfolio
6.2.5 AIM Vaccine Recent Developments/Updates
6.3 Sinovac Biotech
6.3.1 Sinovac Biotech Company Information
6.3.2 Sinovac Biotech Description and Business Overview
6.3.3 Sinovac Biotech Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sinovac Biotech Hepatitis A immunoglobulin Product Portfolio
6.3.5 Sinovac Biotech Recent Developments/Updates
6.4 Pukang Biotechnology
6.4.1 Pukang Biotechnology Company Information
6.4.2 Pukang Biotechnology Description and Business Overview
6.4.3 Pukang Biotechnology Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pukang Biotechnology Hepatitis A immunoglobulin Product Portfolio
6.4.5 Pukang Biotechnology Recent Developments/Updates
6.5 Zhifei Biological Products
6.5.1 Zhifei Biological Products Company Information
6.5.2 Zhifei Biological Products Description and Business Overview
6.5.3 Zhifei Biological Products Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Zhifei Biological Products Hepatitis A immunoglobulin Product Portfolio
6.5.5 Zhifei Biological Products Recent Developments/Updates
6.6 Changchun Lnstitute Of Biological Products
6.6.1 Changchun Lnstitute Of Biological Products Company Information
6.6.2 Changchun Lnstitute Of Biological Products Description and Business Overview
6.6.3 Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Product Portfolio
6.6.5 Changchun Lnstitute Of Biological Products Recent Developments/Updates
6.7 Native Antigen
6.7.1 Native Antigen Company Information
6.7.2 Native Antigen Description and Business Overview
6.7.3 Native Antigen Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Native Antigen Hepatitis A immunoglobulin Product Portfolio
6.7.5 Native Antigen Recent Developments/Updates
6.8 GSK
6.8.1 GSK Company Information
6.8.2 GSK Description and Business Overview
6.8.3 GSK Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 GSK Hepatitis A immunoglobulin Product Portfolio
6.8.5 GSK Recent Developments/Updates
6.9 Merck
6.9.1 Merck Company Information
6.9.2 Merck Description and Business Overview
6.9.3 Merck Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Merck Hepatitis A immunoglobulin Product Portfolio
6.9.5 Merck Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Company Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sanofi Hepatitis A immunoglobulin Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
6.11 Dr. Reddy's Laboratories
6.11.1 Dr. Reddy's Laboratories Company Information
6.11.2 Dr. Reddy's Laboratories Description and Business Overview
6.11.3 Dr. Reddy's Laboratories Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Dr. Reddy's Laboratories Hepatitis A immunoglobulin Product Portfolio
6.11.5 Dr. Reddy's Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hepatitis A immunoglobulin Industry Chain Analysis
7.2 Hepatitis A immunoglobulin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hepatitis A immunoglobulin Production Mode & Process Analysis
7.4 Hepatitis A immunoglobulin Sales and Marketing
7.4.1 Hepatitis A immunoglobulin Sales Channels
7.4.2 Hepatitis A immunoglobulin Distributors
7.5 Hepatitis A immunoglobulin Customer Analysis
8 Hepatitis A immunoglobulin Market Dynamics
8.1 Hepatitis A immunoglobulin Industry Trends
8.2 Hepatitis A immunoglobulin Market Drivers
8.3 Hepatitis A immunoglobulin Market Challenges
8.4 Hepatitis A immunoglobulin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
SINOVAC BIOTECH
GSK
Sanofi
Dr. Reddy’s Laboratories
AIM Vaccine
Pukang Biotechnology
Zhifei Biological Products
Changchun Lnstitute Of Biological Products
Native Antigen
Merck
CSL Behring
List of Tables
 Table 1. Global Hepatitis A immunoglobulin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Hepatitis A immunoglobulin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Hepatitis A immunoglobulin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Hepatitis A immunoglobulin Sales (Doses) of Key Manufacturers (2020-2025)
 Table 5. Global Hepatitis A immunoglobulin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Hepatitis A immunoglobulin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Hepatitis A immunoglobulin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Hepatitis A immunoglobulin Average Price (US$/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Hepatitis A immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Hepatitis A immunoglobulin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Hepatitis A immunoglobulin, Product Type & Application
 Table 12. Global Key Manufacturers of Hepatitis A immunoglobulin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hepatitis A immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis A immunoglobulin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hepatitis A immunoglobulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Hepatitis A immunoglobulin Sales by Region (2020-2025) & (Doses)
 Table 18. Global Hepatitis A immunoglobulin Sales Market Share by Region (2020-2025)
 Table 19. Global Hepatitis A immunoglobulin Sales by Region (2026-2031) & (Doses)
 Table 20. Global Hepatitis A immunoglobulin Sales Market Share by Region (2026-2031)
 Table 21. Global Hepatitis A immunoglobulin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Hepatitis A immunoglobulin Revenue Market Share by Region (2020-2025)
 Table 23. Global Hepatitis A immunoglobulin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Hepatitis A immunoglobulin Revenue Market Share by Region (2026-2031)
 Table 25. North America Hepatitis A immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Hepatitis A immunoglobulin Sales by Country (2020-2025) & (Doses)
 Table 27. North America Hepatitis A immunoglobulin Sales by Country (2026-2031) & (Doses)
 Table 28. North America Hepatitis A immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Hepatitis A immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Hepatitis A immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Hepatitis A immunoglobulin Sales by Country (2020-2025) & (Doses)
 Table 32. Europe Hepatitis A immunoglobulin Sales by Country (2026-2031) & (Doses)
 Table 33. Europe Hepatitis A immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Hepatitis A immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Hepatitis A immunoglobulin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Hepatitis A immunoglobulin Sales by Region (2020-2025) & (Doses)
 Table 37. Asia Pacific Hepatitis A immunoglobulin Sales by Region (2026-2031) & (Doses)
 Table 38. Asia Pacific Hepatitis A immunoglobulin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Hepatitis A immunoglobulin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Hepatitis A immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Hepatitis A immunoglobulin Sales by Country (2020-2025) & (Doses)
 Table 42. Latin America Hepatitis A immunoglobulin Sales by Country (2026-2031) & (Doses)
 Table 43. Latin America Hepatitis A immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Hepatitis A immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Hepatitis A immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Hepatitis A immunoglobulin Sales by Country (2020-2025) & (Doses)
 Table 47. Middle East and Africa Hepatitis A immunoglobulin Sales by Country (2026-2031) & (Doses)
 Table 48. Middle East and Africa Hepatitis A immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Hepatitis A immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Hepatitis A immunoglobulin Sales (Doses) by Type (2020-2025)
 Table 51. Global Hepatitis A immunoglobulin Sales (Doses) by Type (2026-2031)
 Table 52. Global Hepatitis A immunoglobulin Sales Market Share by Type (2020-2025)
 Table 53. Global Hepatitis A immunoglobulin Sales Market Share by Type (2026-2031)
 Table 54. Global Hepatitis A immunoglobulin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Hepatitis A immunoglobulin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Hepatitis A immunoglobulin Revenue Market Share by Type (2020-2025)
 Table 57. Global Hepatitis A immunoglobulin Revenue Market Share by Type (2026-2031)
 Table 58. Global Hepatitis A immunoglobulin Price (US$/Dose) by Type (2020-2025)
 Table 59. Global Hepatitis A immunoglobulin Price (US$/Dose) by Type (2026-2031)
 Table 60. Global Hepatitis A immunoglobulin Sales (Doses) by Application (2020-2025)
 Table 61. Global Hepatitis A immunoglobulin Sales (Doses) by Application (2026-2031)
 Table 62. Global Hepatitis A immunoglobulin Sales Market Share by Application (2020-2025)
 Table 63. Global Hepatitis A immunoglobulin Sales Market Share by Application (2026-2031)
 Table 64. Global Hepatitis A immunoglobulin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Hepatitis A immunoglobulin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Hepatitis A immunoglobulin Revenue Market Share by Application (2020-2025)
 Table 67. Global Hepatitis A immunoglobulin Revenue Market Share by Application (2026-2031)
 Table 68. Global Hepatitis A immunoglobulin Price (US$/Dose) by Application (2020-2025)
 Table 69. Global Hepatitis A immunoglobulin Price (US$/Dose) by Application (2026-2031)
 Table 70. CSL Behring Company Information
 Table 71. CSL Behring Description and Business Overview
 Table 72. CSL Behring Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 73. CSL Behring Hepatitis A immunoglobulin Product
 Table 74. CSL Behring Recent Developments/Updates
 Table 75. AIM Vaccine Company Information
 Table 76. AIM Vaccine Description and Business Overview
 Table 77. AIM Vaccine Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 78. AIM Vaccine Hepatitis A immunoglobulin Product
 Table 79. AIM Vaccine Recent Developments/Updates
 Table 80. Sinovac Biotech Company Information
 Table 81. Sinovac Biotech Description and Business Overview
 Table 82. Sinovac Biotech Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 83. Sinovac Biotech Hepatitis A immunoglobulin Product
 Table 84. Sinovac Biotech Recent Developments/Updates
 Table 85. Pukang Biotechnology Company Information
 Table 86. Pukang Biotechnology Description and Business Overview
 Table 87. Pukang Biotechnology Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 88. Pukang Biotechnology Hepatitis A immunoglobulin Product
 Table 89. Pukang Biotechnology Recent Developments/Updates
 Table 90. Zhifei Biological Products Company Information
 Table 91. Zhifei Biological Products Description and Business Overview
 Table 92. Zhifei Biological Products Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 93. Zhifei Biological Products Hepatitis A immunoglobulin Product
 Table 94. Zhifei Biological Products Recent Developments/Updates
 Table 95. Changchun Lnstitute Of Biological Products Company Information
 Table 96. Changchun Lnstitute Of Biological Products Description and Business Overview
 Table 97. Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 98. Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Product
 Table 99. Changchun Lnstitute Of Biological Products Recent Developments/Updates
 Table 100. Native Antigen Company Information
 Table 101. Native Antigen Description and Business Overview
 Table 102. Native Antigen Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 103. Native Antigen Hepatitis A immunoglobulin Product
 Table 104. Native Antigen Recent Developments/Updates
 Table 105. GSK Company Information
 Table 106. GSK Description and Business Overview
 Table 107. GSK Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 108. GSK Hepatitis A immunoglobulin Product
 Table 109. GSK Recent Developments/Updates
 Table 110. Merck Company Information
 Table 111. Merck Description and Business Overview
 Table 112. Merck Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 113. Merck Hepatitis A immunoglobulin Product
 Table 114. Merck Recent Developments/Updates
 Table 115. Sanofi Company Information
 Table 116. Sanofi Description and Business Overview
 Table 117. Sanofi Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 118. Sanofi Hepatitis A immunoglobulin Product
 Table 119. Sanofi Recent Developments/Updates
 Table 120. Dr. Reddy's Laboratories Company Information
 Table 121. Dr. Reddy's Laboratories Description and Business Overview
 Table 122. Dr. Reddy's Laboratories Hepatitis A immunoglobulin Sales (Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 123. Dr. Reddy's Laboratories Hepatitis A immunoglobulin Product
 Table 124. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Hepatitis A immunoglobulin Distributors List
 Table 128. Hepatitis A immunoglobulin Customers List
 Table 129. Hepatitis A immunoglobulin Market Trends
 Table 130. Hepatitis A immunoglobulin Market Drivers
 Table 131. Hepatitis A immunoglobulin Market Challenges
 Table 132. Hepatitis A immunoglobulin Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hepatitis A immunoglobulin
 Figure 2. Global Hepatitis A immunoglobulin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hepatitis A immunoglobulin Market Share by Type: 2024 & 2031
 Figure 4. Inactivated Product Picture
 Figure 5. Attenuated Product Picture
 Figure 6. Global Hepatitis A immunoglobulin Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Hepatitis A immunoglobulin Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Pharmacy
 Figure 10. Other
 Figure 11. Global Hepatitis A immunoglobulin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Hepatitis A immunoglobulin Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Hepatitis A immunoglobulin Sales (2020-2031) & (Doses)
 Figure 14. Global Hepatitis A immunoglobulin Average Price (US$/Dose) & (2020-2031)
 Figure 15. Hepatitis A immunoglobulin Report Years Considered
 Figure 16. Hepatitis A immunoglobulin Sales Share by Manufacturers in 2024
 Figure 17. Global Hepatitis A immunoglobulin Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Hepatitis A immunoglobulin Players: Market Share by Revenue in Hepatitis A immunoglobulin in 2024
 Figure 19. Hepatitis A immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Hepatitis A immunoglobulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Hepatitis A immunoglobulin Sales Market Share by Country (2020-2031)
 Figure 22. North America Hepatitis A immunoglobulin Revenue Market Share by Country (2020-2031)
 Figure 23. United States Hepatitis A immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Hepatitis A immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Hepatitis A immunoglobulin Sales Market Share by Country (2020-2031)
 Figure 26. Europe Hepatitis A immunoglobulin Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Hepatitis A immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Hepatitis A immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Hepatitis A immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Hepatitis A immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Hepatitis A immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Hepatitis A immunoglobulin Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Hepatitis A immunoglobulin Revenue Market Share by Region (2020-2031)
 Figure 34. China Hepatitis A immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Hepatitis A immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Hepatitis A immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Hepatitis A immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Hepatitis A immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Hepatitis A immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Hepatitis A immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Hepatitis A immunoglobulin Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Hepatitis A immunoglobulin Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Hepatitis A immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Hepatitis A immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Hepatitis A immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Hepatitis A immunoglobulin Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Hepatitis A immunoglobulin Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Hepatitis A immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Hepatitis A immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Hepatitis A immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Hepatitis A immunoglobulin by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Hepatitis A immunoglobulin by Type (2020-2031)
 Figure 53. Global Hepatitis A immunoglobulin Price (US$/Dose) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Hepatitis A immunoglobulin by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Hepatitis A immunoglobulin by Application (2020-2031)
 Figure 56. Global Hepatitis A immunoglobulin Price (US$/Dose) by Application (2020-2031)
 Figure 57. Hepatitis A immunoglobulin Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Intravenous Injection Immunoglobulin Market Research Report 2024
Global Hepatitis B Human Immunoglobulin Market Research Report 2024
Global Hepatitis B Immune Globulin Market Research Report 2025
Global Human Hepatitis B Immunoglobulin HBIG Market Research Report 2025
Global Human Hepatitis B Immunoglobulin for Intravenous Injection Market Research Report 2024
Anti Hepatitis Virus Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Immunoglobulin Market Research Report 2024
Global Hepatitis Virus Infection Test Kit Market Research Report 2025
Global Antivenom Immunoglobulin Market Research Report 2025
Global Hepatitis Test Kits Market Insights Forecast to 2030
Global Hepatitis Viruses Rapid Tests Market Research Report 2025
Global Rapid Hepatitis Testing Market Research Report 2024
Immune Globulins Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis E Virus IgG anti diagnostic Kit Market Research Report 2024
Hepatitis Virus Detection Reagent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti tetanus Immunoglobulin Market Research Report 2024
Global Hepatitis B Test Strip Market Research Report 2025
Hepatic Antiviral Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Streptococcus Group A Antibodies Market Research Report 2024
Global Hepatitis A Vaccination Market Research Report 2025

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions